Organization
Westlake University
1 clinical trial
2 abstracts
Abstract
Erythrocyte-αPD-1 conjugates overcome resistance to checkpoint blockade immunotherapy: A first-in-human study.Org: Westlake University, Zhejiang Province People’s Hospital, School of Life Sciences, Institute of Basic Medical Sciences, Westlake Institute for Advanced Study,
Clinical trial
A Study of the Efficacy of Troxerutin in Preventing Thrombotic Events in COVID-19 PatientsStatus: Recruiting, Estimated PCD: 2024-09-01
Abstract
WTX212, an erythrocyte-anti-PD1 antibody conjugate, to demonstrate anti-tumor activities in tumor models and patients with cancer with acquired resistance to immunotherapy.Org: Westlake University, Westlake Institute for Advanced Study, Westlake Therapeutics Co., Ltd.,